Details of the Drug Therapeutic Target (DTT)
General Information of Drug Therapeutic Target (DTT) (ID: TTW14O3)
DTT Name | Programmed cell death 1 ligand 2 (PD-L2) | ||||
---|---|---|---|---|---|
Synonyms | Programmed death ligand 2; PDL2; PDCD1L2; PDCD1 ligand 2; PD-1 ligand 2; CD273; Butyrophilin B7-DC; B7DC; B7-DC | ||||
Gene Name | PDCD1LG2 | ||||
DTT Type |
Patented-recorded target
|
[1] | |||
BioChemical Class |
Immunoglobulin
|
||||
UniProt ID | |||||
TTD ID | |||||
3D Structure | |||||
Sequence |
MIFLLLMLSLELQLHQIAALFTVTVPKELYIIEHGSNVTLECNFDTGSHVNLGAITASLQ
KVENDTSPHRERATLLEEQLPLGKASFHIPQVQVRDEGQYQCIIIYGVAWDYKYLTLKVK ASYRKINTHILKVPETDEVELTCQATGYPLAEVSWPNVSVPANTSHSRTPEGLYQVTSVL RLKPPPGRNFSCVFWNTHVRELTLASIDLQSQMEPRTHPTWLLHIFIPFCIIAFIFIATV IALRKQLCQKLYSSKDTTKRPVTTTKREVNSAI |
||||
Function |
Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner.
|
||||
KEGG Pathway | |||||
Reactome Pathway | |||||